Examples of 'anti-angiogenesis' in a sentence
Meaning of "anti-angiogenesis"
anti-angiogenesis (adjective) - Anti-angiogenesis refers to the process of inhibiting the growth of new blood vessels. This term is often used in the context of cancer treatment, where anti-angiogenic drugs are used to prevent the formation of blood vessels that nourish tumors
How to use "anti-angiogenesis" in a sentence
Basic
Advanced
anti-angiogenesis
The answer may be anti-angiogenesis drugs.
Anti-angiogenesis agents include receptor tyrosine kinase inhibitors.
But there was a whole section on anti-angiogenesis.
Anti-angiogenesis is a valid strategy when employing pancreatic cancer target therapy.
Identification of subjects being susceptible to anti-angiogenesis therapy.
The phenomenon of anti-angiogenesis was the absence of at least one intersegmental vessel.
Another area receiving considerable attention is anti-angiogenesis therapy.
Preferably the anti-angiogenesis factor is administered prior to administration of the photosensitizer.
It is also believed that interferons possess anti-angiogenesis activity.
The anti-angiogenesis factor and photosensitizer preferably are provided in separate containers.
Indirect evidence for anti-angiogenesis is presented below.
The pharmaceutically active agent comprises a macromolecular anti-angiogenesis component.
Anti-angiogenesis is also less likely to pose a drug resistance problem compared to conventional chemotherapeutics.
The present invention relates to the field of anti-angiogenesis compositions.
The anti-angiogenesis effect of parenterally administered compounds can be prolonged by slowing their absorption.
See also
Spanish gene expression data promise targeting of anti-angiogenesis treatment.
Anti-angiogenesis therapies have become an important treatment option for several types of tumors.
Hypoxia is used as an in vitro surrogate for anti-angiogenesis therapy such as bevacizumab.
Numerous clinical trials have been conducted in hope of finding an effective drug for anti-angiogenesis.
For said subject a therapy other than an anti-angiogenesis therapy shall be considered.
The combination of anti-angiogenesis and immune checkpoint inhibitors could produce synergistic antitumor effects.
In one embodiment, the cancer therapy is treatment with an anti-angiogenesis agent.
Thus, the subject shall not be on anti-angiogenesis therapy when the sample is obtained.
Given this information, we understand why many cancer treatments include anti-angiogenesis therapy.
The anti-angiogenesis factor may be synthesized using methodologies known and used in the art.
This effect might be a direct effect on tumor cells or an anti-angiogenesis mediated effect.
Such anti-angiogenesis agents can act at the cell surface to inhibit the pro-angiogenesis agents.
In preferred embodiments, the pharmaceutically active agent can comprise a macromolecular anti-angiogenesis component.
The two modalities of anti-angiogenesis agent and integrin-blocking agent together have a synergistic effect.
The method of the present invention is for subjects who shall start anti-angiogenesis therapy.
The combination of cell-killing anti-angiogenesis with cell stasis anti-angiogenesis could be a powerful chemotherapeutic combination.
Some scientists are developing drugs that cut off blood vessel growth, an approach called anti-angiogenesis.
The present invention also includes compositions comprising an anti-angiogenesis compound and an antiinflammatory compound.
Other anti-angiogenesis agents may include inhibitors of VEGF transcription.
Other drugs that can administered with the agent include growth factor inhibitors, or anti-angiogenesis factors.
The anti-angiogenesis factor preferably is administered to the mammal prior to PDT.
Instructions for such administration may be provided with the anti-angiogenesis factor and / or with the photosensitizer.
Furthermore, the anti-angiogenesis factor can potentiate the cytotoxicity of PDT.
New MR analysis technique reveals brain tumor response to anti-angiogenesis therapy.
Anti-Angiogenesis Metronomic is a new approaches by attacking the tumor's blood supply thus depriving it food.
Methods of delivering polynucleotides of the invention are described in more detail herein . Anti-Angiogenesis Activity.
The anti-angiogenesis agent.
VEGF polymorphisms and anti-angiogenesis therapy.
Thus, anti-angiogenesis treatments are useful in combating all these conditions.
A new, very promising cancer therapy is anti-angiogenesis therapy.
Preferably, an anti-angiogenesis therapy relates to a drug-based anti-angiogenesis therapy.
These molecules can be for example pro - or anti-angiogenesis molecules.
Therefore, anti-angiogenesis has become a focus in the development of new anti-cancer drugs.
In one embodiment the anti-cancer agent is an anti-angiogenesis agent.
Currently, the combination of anti-angiogenesis drugs with chemotherapy / radiation is the most effect treatment.
